Castle Biosciences 10K Form

Sell

26

CSTL
Castle Biosciences

Last Price:

$27.09

Seasonality Move:

-4.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-09	10Q	CSTL/Castle Biosciences Quarterly
2020-08-10	10Q	CSTL/Castle Biosciences Quarterly
2020-05-11	10Q	CSTL/Castle Biosciences Quarterly
2020-03-10	10K	CSTL/Castle Biosciences Annual
2019-11-12	10Q	CSTL/Castle Biosciences Quarterly
2019-09-03	10Q	CSTL/Castle Biosciences Quarterly

Receive CSTL News And Ratings

See the #1 stock for the next 7 days that we like better than CSTL

CSTL Financial Statistics

Sales & Book Value

Annual Sales:	$219.8M
Cash Flow:	$17M
Price / Cash Flow:	22.61
Annual Sales:	$15.77
Price / Book:	1.76

Profitability

EPS (TTM):	0.21000
Net Income (TTM):	$6.1M
Gross Margin:	$174.8M
Return on Equity:	1.49%
Return on Assets:	1.29%

Castle Biosciences Earnings Forecast

Key Castle Biosciences Financial Ratios

The Gross Profit Margin over the past 7 years for CSTL is 79.53%.
The Selling, General & Administrative Expenses for CSTL have been equal to 81.97% of Gross Profit Margin.
The Research & Development expenses have been 24.40% of Revenue.
The Interest Expense is -0.02% of Operating Income.
The Net Earning history of CSTL is -26.15% of Total Revenues.
Per Share Earnings over the last 7 years have been positive in 3 years.

Castle Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Health Care Providers & Services
Sector:	Health Care
Current Symbol:	CSTL
CUSIP:	14843C
Website:	castlebiosciences.com

Debt

Debt-to-Equity Ratio:	0.02
Current Ratio:	7.78
Quick Ratio:	7.45

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

CSTL Technical Analysis vs Fundamental Analysis

Sell

26

Castle Biosciences (CSTL) is a Sell

Is Castle Biosciences a Buy or a Sell?

Castle Biosciences stock is rated a Sell

The current Castle Biosciences [CSTL] share price is $27.72. The Score for CSTL is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.